The WHO announced that the last Ebola patient in Congo’s latest outbreak was discharged over the weekend and no new cases ...

BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric cancer study, improving overall ...

From STAT’s Adam Feuerstein: Let’s start with Replimune, which said this morning the Food and Drug Administration will review ...

At a major cancer conference, Merck rolled out some showstoppers — data on drugs on which its business future may depend.

Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead ...

AI tools designed to make health care more efficient are ubiquitous, though many remain piecemeal and siloed, as researchers ...

Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...

Trump administration's stance on involuntary commitment for people with addiction isn't supported by evidence, an addiction ...

Gestational surrogacy faces serious threats from a powerful alliance that includes religious groups, MAHA supporters, and ...

Mark Sendak was getting tired of seeing the toil of so many colleagues go to waste. At Duke University, he was part of a team ...

Safeguarding biodiversity is not simply an environmental concern but a foundational element of preventive and clinical care.

AstraZeneca and Gilead both reported successful trials in a hard-to-treat form of breast cancer, sparking a debate about ...